Vitamin D and its analogs as regulators of immune activation and antigen presentation

被引:186
作者
Griffin, MD
Xing, NZ
Kumar, R
机构
[1] Mayo Clin & Mayo Fdn, Dept Internal Med, Div Nephrol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Mayo Proteom Res Ctr, Rochester, MN 55905 USA
关键词
T lymphocytes; B lymphocytes; dendritic cells; autoimmunity; transplantation;
D O I
10.1146/annurev.nutr.23.011702.073114
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
It has been a little more than 20 years since the first appreciation that the biologically active hormonal form of the secosteroid vitamin D-classically categorized as a regulator of calcium/phosphorous metabolism and bone mineralization-can exert effects on cells of the immune system. Since then a substantial literature has accumulated to suggest that these effects are exerted on multiple immune cell types, are predominantly suppressive at pharmacologic levels, and are potent enough to have true therapeutic potential in the management or prevention of immune-mediated diseases. Less clear at present, however, are the physiological roles played by the vitamin D endocrine system in the regulation of normal and abnormal immune responses. In this review, an appraisal of the current understanding of vitamin D-mediated immune regulation is presented that emphasizes progress towards its clinical application as well as the manner in which emerging models of normal immune function may facilitate a more complete understanding of its physiologic significance.
引用
收藏
页码:117 / 145
页数:31
相关论文
共 147 条
[21]  
BOUILLON R, 1991, J BONE MINER RES, V6, P1051
[22]  
BRANISTEANU DD, 1993, CLIN EXP IMMUNOL, V94, P412
[23]   Synergism between sirolimus and 1,25-dihydroxyvitamin D-3 in vitro and in vivo [J].
Branisteanu, DD ;
Mathieu, C ;
Bouillon, R .
JOURNAL OF NEUROIMMUNOLOGY, 1997, 79 (02) :138-147
[24]   PREVENTION OF MURINE EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS - COOPERATIVE EFFECTS OF CYCLOSPORINE AND 1ALPHA,25-(OH)(2)D-3 [J].
BRANISTEANU, DD ;
WAER, M ;
SOBIS, H ;
MARCELIS, S ;
VANDEPUTTE, M ;
BOUILLON, R .
JOURNAL OF NEUROIMMUNOLOGY, 1995, 61 (02) :151-160
[25]  
BRENNAN A, 1987, IMMUNOLOGY, V61, P457
[26]   1,25(OH)2D3 PRODUCTION BY LYMPHOCYTE-T AND ALVEOLAR MACROPHAGES RECOVERED BY LAVAGE FROM NORMOCALCEMIC PATIENTS WITH TUBERCULOSIS [J].
CADRANEL, J ;
GARABEDIAN, M ;
MILLERON, B ;
GUILLOZO, H ;
AKOUN, G ;
HANCE, AJ .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (05) :1588-1593
[27]   1-α,25-dihydroxyvitamin D3 (1,25(OH)2D3) hampers the maturation of fully active immature dendritic cells from monocytes [J].
Canning, MO ;
Grotenhuis, K ;
de Wit, H ;
Ruwhof, C ;
Drexhage, HA .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 145 (03) :351-357
[28]   Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice [J].
Cantorna, MT ;
Humpal-Winter, J ;
DeLuca, HF .
JOURNAL OF NUTRITION, 1999, 129 (11) :1966-1971
[29]   1,25-dihydroxyvitamin D-3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis [J].
Cantorna, MT ;
Hayes, CE ;
DeLuca, HF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :7861-7864
[30]   1,25-dihydroxyvitamin D3 prolongs graft survival without compromising host resistance to infection or bone mineral density [J].
Cantorna, MT ;
Hullett, DA ;
Redaelli, C ;
Brandt, CR ;
Humpal-Winter, J ;
Sollinger, HW ;
DeLuca, HF .
TRANSPLANTATION, 1998, 66 (07) :828-831